Latest article
The Rise of Vietnam’s First Cancer Drug Manufacturer: Expanding Horizons Through Strategic Tendering
Our cancer treatment drugs are competitively priced, offering hospitals and patients more economical choices. With our affordable options, we aim to provide greater accessibility and financial flexibility in cancer treatment, ensuring that quality care is within reach for those who need it most.
“Dragon Capital Divests 5.5 Million DXG Shares of Dat Xanh Group”
Dragon Capital has offloaded 5.5 million DXG shares, reducing its ownership stake in Dat Xanh Group from 10.0833% to 9.3201%.
“Transforming VNSteel’s Capital Transfer Plans at Thép Vicasa”
VNSteel plans to divest its entire stake of 9.87 million shares, equivalent to 65% of the capital of Vicasa Joint Stock Company - VNSteel (code VCA-HOSE). This divestment can be executed through two potential scenarios.
